The Italy dental care market is projected to grow from $861 Mn in 2022 to $1,362 Mn in 2030 with a CAGR of 5.9% for the year 2022-2030. Technological advancements such as 3D printing for diagnoses and robotic technologies for prostheses are future drivers for the Italy dental care market.
The Italy patient support programs market is projected to grow during the forecast period as the demand for patient-centric care is increasing in Italy. PSOLife care by Novartis, Hemozone by BioVIIIx, and Clickservice by Merck are major pharma-sponsored PSPs in Italy.